InforCapital
Startup Fundraising

Eight Sleep Raises $50M at $1.5B Valuation

Eight Sleep secures $50M led by Tether Investments at $1.5B valuation, focusing on AI-driven health tech and global expansion.

AM
Alvaro de la Maza

Partner at Aninver

Key Takeaways

  • Eight Sleep raised $50.0M (Series G) from Tether Investments, HSG, Valor Equity Partners, Founders Fund, Y Combinator.
  • Sector: Healthcare, Healthtech & Medtech, Technology, Software & Gaming, Consumer.
  • Geography: United States.

Analysis

Eight Sleep, a pioneer in smart sleep technology, has successfully closed a $50 million funding round, achieving a $1.5 billion valuation. This strategic infusion of capital, led by Tether Investments, signals a significant step forward for the company as it pivots towards becoming a comprehensive health technology entity. The funding follows a substantial $100 million raise in August of the previous year, which saw participation from prominent investors including HSG, Valor Equity Partners, Founders Fund, and Y Combinator.

The company's trajectory demonstrates impressive growth since its $86 million Series C round in 2021, where it was valued at $500 million post-money. With over $310 million raised to date, Eight Sleep has established a strong foundation. Crucially, the company achieved free-cash-flow positivity in 2025, a testament to its operational efficiency and market traction in the competitive sleep-enhancement sector, which is projected to grow significantly as consumer focus on wellness intensifies.

This latest funding will be instrumental in driving Eight Sleep's ambitious expansion plans. The capital injection is earmarked for the development of innovative new products, facilitating global market penetration, and crucially, pursuing clinical validation for its advanced sleep solutions. Currently, Eight Sleep's smart mattress accessories, designed to track sleep patterns and dynamically adjust bedroom temperatures, are available in over 34 countries, highlighting its established international reach.

A key strategic objective for Eight Sleep is to transcend its current consumer product offerings. The company is actively seeking U.S. Food and Drug Administration (FDA) approval for novel products aimed at detecting and mitigating sleep apnea, a condition affecting millions worldwide. This move positions Eight Sleep at the intersection of consumer electronics and medical-grade health solutions, a rapidly expanding market segment driven by an aging population and increased awareness of chronic health conditions.

At the core of Eight Sleep's future vision is the development of a sophisticated, sleep-focused AI agent. This intelligent system is designed to proactively manage environmental factors such as temperature, elevation, and firmness of sleep surfaces, aiming to preemptively eliminate sleep disruptions. The AI will simulate various user scenarios before bedtime, optimizing product settings for peak sleep quality. This advanced application of AI leverages proprietary data, with early trials showing significant user habit changes in areas like exercise timing and caffeine intake, directly influenced by the AI's personalized guidance.

Matteo Franceschetti, co-founder and CEO of Eight Sleep, articulated the company's bold mission: “What we’re building doesn’t exist yet — a system that understands your body better each night and acts on that knowledge. Our goal is to build the defining health technology company of this generation.” This statement underscores the company's commitment to creating a holistic sleep ecosystem that goes beyond mere comfort to actively improve user health and well-being, differentiating it from competitors like BedJet and Chilipad in temperature control, and Oura and Whoop in sleep tracking.